ALXO
USDALX Oncology Holdings Inc. Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$1.520
Hoch
$1.600
Tief
$1.460
Volumen
0.54M
Unternehmensfundamentaldaten
Marktkapitalisierung
78.2M
Branche
Biotechnologie
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
0.93M
Börse
NMS
Währung
USD
52-Wochen-Spanne
Ähnliche Nachrichten
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (NASDAQ:ALXO), a clinical-stage biotechnology company advancing a pipeline of
ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
-Two poster presentations showcase best- and first-in-class potential of ALX2004, a novel, antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors -Robust body of preclinical data supports
Ähnliche Aktien
ONBPO
Old National Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of Series C Preferred Stock
ACON
Aclarion Inc.
CLIR
ClearSign Technologies Corporation (DE)
TENX
Tenax Therapeutics Inc.
ELYM
Eliem Therapeutics Inc
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.